Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Investigational new drugs 2019-06, Vol.37 (3), p.591-591
Hauptverfasser: Ito, Tetsuhide, Okusaka, Takuji, Nishida, Toshirou, Yamao, Kenji, Igarashi, Hisato, Morizane, Chigusa, Kondo, Shunsuke, Mizuno, Nobumasa, Hara, Kazuo, Sawaki, Akira, Hashigaki, Satoshi, Kimura, Nobuyuki, Murakami, Mami, Ohki, Emiko, Chao, Richard C., Imamura, Masayuki
Format: Artikel
Sprache:eng
Schlagworte:
Correction
Medicine
Medicine & Public Health
Metastases
Neuroendocrine tumors
Oncology
Pancreas
Pharmacology/Toxicology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.
ISSN:0167-6997
1573-0646
DOI:10.1007/s10637-019-00757-9